What Is GHK-Cu? Benefits, Research & Safety

GHK-Cu was first isolated from human plasma in 1973 by Dr. Loren Pickart during research into factors that could reverse liver damage. The tripeptide was found to stimulate the synthesis of collagen and other matrix proteins by hepatocytes, leading to further investigation of its biological properties. Throughout the 1980s and 1990s, research expanded to explore GHK-Cu's effects on wound healing and skin regeneration. Studies demonstrated that the peptide could accelerate wound closure, increase collagen synthesis, and promote new blood vessel formation at injury sites. The discovery that GHK-Cu could stimulate hair follicle growth further expanded interest in its potential applications. Clinical studies in the 1990s showed improvements in skin texture, elasticity, and firmness when GHK-Cu was applied topically. In the 2000s, gene array studies revealed that GHK-Cu modulates the expression of thousands of genes, many involved in tissue repair, antioxidant responses, and anti-inflammatory pathways. This broad gene-regulatory activity helped explain the peptide's diverse biological effects. GHK-Cu has been incorporated into numerous commercial skincare products, making it one of the few peptides with widespread availability in cosmetic formulations. Research continues into its potential therapeutic applications beyond cosmetic use.